FDA compliance

Reminder: FDA VQIP Applications for FY2027 Close September 1

Short summary: The FDA has announced that the application window for Fiscal Year 2027 Voluntary Qualified Importer Program (VQIP) benefits closes on September 1, 2026. For companies importing FDA-regulated food products, the approaching deadline is a reminder to confirm eligibility, supplier certifications, and application readiness before time runs out.

Deadline and Program Overview

Food importers seeking faster FDA entry processing should take note: the application period for the FDA’s Voluntary Qualified Importer Program (VQIP) for Fiscal Year 2027 closes on September 1, 2026.

VQIP is a fee-based program established under the Food Safety Modernization Act (FSMA) that rewards importers with strong supply chain controls and demonstrated food safety compliance. Approved participants may benefit from expedited review and importation of eligible human and animal food products entering the United States.

Applications approved for FY2027 will provide benefits beginning October 1, 2026, provided the FDA receives both an approved application and the required user fee payment.

Eligibility Requirements 

Importers should not assume they qualify automatically. One of the most common barriers to participation is the requirement that all foreign suppliers associated with VQIP-covered products maintain a valid facility certification issued by an FDA-accredited certification body under the FDA’s Accredited Third-Party Certification Program.

Importers considering VQIP participation should verify:

  • Foreign suppliers hold current certifications from FDA-accredited certification bodies.
  • Required regulatory audits have been completed.
  • Supply chain documentation and food safety controls meet FDA expectations.
  • Internal records are current and ready for submission through the VQIP portal.

Why Importers Should Consider VQIP

For qualifying importers, VQIP can provide meaningful operational advantages, including:

  • Expedited […]

FDA Announces One-Day Inspection Pilot

The U.S. Food and Drug Administration (FDA) announced that it is piloting one-day inspectional assessments. These assessments will be shorter, more focused, and will complement existing standard FDA inspections.  

Shorter Inspections, More Coverage 

Launched in April 2026, the pilot is part of a broader initiative to make the agency’s inspectional resources more targeted and efficient. The new assessments will allow for broader coverage, enabling the agency to assess more facilities without compromising regulatory rigor. 

The pilot is being conducted across multiple FDA inspectorates, including human and animal foods, biologics, medical products, and clinical research programs. Facilities are selected using risk-based criteria such as:  

  • Product type 
  • Prior inspection outcomes 
  • Operational characteristics  

As of late April 2026, the FDA has completed approximately 46 one-day assessments.  

The agency made clear that one-day inspectional assessments are not intended to replace standard FDA inspections. Instead, they are meant to provide an additional tool to the agency’s enforcement approach. The ‘one-day’ framework is also flexible – investigators retain authority to expand the scope or duration of an assessment if warranted.  

The pilot will continue through fiscal year 2026. The FDA is currently developing evaluation metrics to assess effectiveness, including inspection duration, escalation rates, and the utility of findings in informing risk-based decision-making. 

What Facility Owners and Operators Should Do 

Facility owners and operators should remain ready […]

Go to Top